Sana Biotechnology (SANA) Long-Term Investments (2020 - 2023)

Sana Biotechnology has reported Long-Term Investments for 4 years, with the latest figure at $5.8 million in Q1 2023.

• Quarterly Long-Term Investments fell 95.98% year-over-year to $5.8 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $5.8 million (down 95.98% YoY) and the FY2022 annual result came in at $10.1 million, down 94.87% from the prior year.
• Long-Term Investments retreated to $5.8 million in Q1 2023 per SANA's latest filing, from $10.1 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $262.4 million in Q3 2021 and troughed at $5.8 million in Q1 2023.
• A 4-year average of $87.3 million and a median of $55.8 million in 2020 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments soared 570.52% in 2022, then tumbled 95.98% in 2023.
• Over 4 years, Long-Term Investments stood at $33.7 million in 2020, then jumped by 480.72% to $195.9 million in 2021, then plunged by 94.87% to $10.1 million in 2022, then slumped by 42.05% to $5.8 million in 2023.
• According to Business Quant data, Long-Term Investments over the past three periods registered $5.8 million, $10.1 million, and $25.8 million for Q1 2023, Q4 2022, and Q3 2022 respectively.